Merck & Co., Inc. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-10-31 | 85.420 | 86.460 | 84.560 | 85.980 | 83.527 | 12,385,000 |
| 2025-10-30 | 84.620 | 87.300 | 83.300 | 86.280 | 83.819 | 16,678,800 |
| 2025-10-29 | 86.950 | 87.840 | 86.070 | 86.580 | 84.110 | 10,921,900 |
| 2025-10-28 | 88.110 | 88.110 | 86.930 | 87.030 | 84.547 | 8,345,900 |
| 2025-10-27 | 87.510 | 88.300 | 87.030 | 88.000 | 85.490 | 7,226,600 |
| 2025-10-24 | 87.330 | 88.060 | 87.110 | 87.490 | 84.994 | 7,902,100 |
| 2025-10-23 | 87.560 | 88.110 | 86.910 | 87.180 | 84.693 | 7,687,500 |
| 2025-10-22 | 87.680 | 88.790 | 87.010 | 87.610 | 85.111 | 10,926,300 |
| 2025-10-21 | 86.960 | 87.670 | 86.230 | 87.620 | 85.121 | 9,852,400 |
| 2025-10-20 | 85.250 | 87.000 | 85.030 | 86.320 | 83.858 | 8,611,800 |
← NewerPage 5 of 5 · 250 trading days
Stock splits
| Date | Split (new : old) |
|---|---|
| 2021-06-03 | 1048:1000 |
| 1999-02-17 | 2:1 |
| 1992-05-26 | 3:1 |
Dividends
| Ex-date | Amount |
|---|---|
| 2026-09-15 | 0.8500 USD |
| 2026-06-15 | 0.8500 USD |
| 2026-03-16 | 0.8500 USD |
| 2025-12-15 | 0.8500 USD |
| 2025-09-15 | 0.8100 USD |
| 2025-06-16 | 0.8100 USD |
| 2025-03-17 | 0.8100 USD |
| 2024-12-16 | 0.8100 USD |
| 2024-09-16 | 0.7700 USD |
| 2024-06-17 | 0.7700 USD |
| 2024-03-14 | 0.7700 USD |
| 2023-12-14 | 0.7700 USD |
| 2023-09-14 | 0.7300 USD |
| 2023-06-14 | 0.7300 USD |
| 2023-03-14 | 0.7300 USD |
| 2022-12-14 | 0.7300 USD |
| 2022-09-14 | 0.6900 USD |
| 2022-06-14 | 0.6900 USD |
| 2022-03-14 | 0.6900 USD |
| 2021-12-14 | 0.6900 USD |
| 2021-09-14 | 0.6500 USD |
| 2021-06-14 | 0.6500 USD |
| 2021-03-12 | 0.6500 USD |
| 2020-12-14 | 0.6500 USD |
| 2020-09-14 | 0.6100 USD |
| 2020-06-12 | 0.6100 USD |
| 2020-03-13 | 0.6100 USD |
| 2019-12-13 | 0.6100 USD |
| 2019-09-13 | 0.5500 USD |
| 2019-06-14 | 0.5500 USD |
| 2019-03-14 | 0.5500 USD |
Open, high, low and close are as traded (USD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.